ONOFRJ, Marco
 Distribuzione geografica
Continente #
NA - Nord America 22.068
EU - Europa 16.427
AS - Asia 14.691
SA - Sud America 2.156
AF - Africa 265
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 37
Totale 55.687
Nazione #
US - Stati Uniti d'America 21.635
SG - Singapore 6.089
CN - Cina 4.006
IT - Italia 3.109
RU - Federazione Russa 2.468
IE - Irlanda 2.224
UA - Ucraina 2.119
BR - Brasile 1.741
GB - Regno Unito 1.532
TR - Turchia 1.449
VN - Vietnam 1.373
SE - Svezia 1.364
DE - Germania 1.267
FR - Francia 968
IN - India 659
FI - Finlandia 586
HK - Hong Kong 290
CA - Canada 242
AR - Argentina 153
MX - Messico 146
BD - Bangladesh 130
NL - Olanda 123
JP - Giappone 122
ZA - Sudafrica 116
PL - Polonia 111
AT - Austria 110
ES - Italia 99
IQ - Iraq 88
CZ - Repubblica Ceca 67
BE - Belgio 66
EC - Ecuador 65
ID - Indonesia 59
PK - Pakistan 52
CO - Colombia 49
KR - Corea 48
VE - Venezuela 45
MA - Marocco 39
UZ - Uzbekistan 36
IR - Iran 35
LT - Lituania 33
CH - Svizzera 31
EU - Europa 31
SA - Arabia Saudita 31
CL - Cile 30
AE - Emirati Arabi Uniti 28
AU - Australia 27
LU - Lussemburgo 27
EG - Egitto 26
IL - Israele 24
PH - Filippine 23
PY - Paraguay 22
PE - Perù 21
JO - Giordania 19
RO - Romania 18
TN - Tunisia 18
MY - Malesia 17
PT - Portogallo 15
AZ - Azerbaigian 14
NZ - Nuova Zelanda 14
UY - Uruguay 14
DZ - Algeria 13
KE - Kenya 13
GR - Grecia 12
OM - Oman 12
JM - Giamaica 11
BG - Bulgaria 10
DK - Danimarca 10
KG - Kirghizistan 10
NP - Nepal 10
BO - Bolivia 9
SN - Senegal 9
AL - Albania 8
AO - Angola 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
KZ - Kazakistan 8
LB - Libano 8
NO - Norvegia 8
HU - Ungheria 7
RS - Serbia 7
HN - Honduras 6
HR - Croazia 6
TW - Taiwan 6
AM - Armenia 5
CR - Costa Rica 5
LV - Lettonia 5
PA - Panama 5
GE - Georgia 4
GY - Guiana 4
NG - Nigeria 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
BH - Bahrain 3
CY - Cipro 3
GH - Ghana 3
KH - Cambogia 3
LK - Sri Lanka 3
Totale 55.637
Città #
Singapore 4.459
Chandler 2.662
Jacksonville 2.442
San Jose 2.314
Dublin 2.188
Ashburn 1.596
Princeton 1.060
Dallas 1.014
Beijing 973
Southend 965
Izmir 752
Nanjing 684
Los Angeles 590
Wilmington 516
Santa Clara 451
Ho Chi Minh City 449
Munich 421
The Dalles 414
Dearborn 412
Cambridge 377
Altamura 373
New York 372
Chieti 320
Ann Arbor 312
Hanoi 285
Tongling 284
Buffalo 272
Hong Kong 247
Nanchang 241
Boardman 219
Moscow 207
São Paulo 196
Woodbridge 195
Council Bluffs 193
Rome 167
Redondo Beach 151
Houston 141
Milan 138
Pescara 138
Shenyang 129
Orem 126
Helsinki 124
Hebei 123
Tianjin 111
Montreal 99
Washington 97
Tokyo 96
Jiaxing 92
Kunming 91
London 91
Turku 90
Chennai 89
Hefei 89
Warsaw 89
Brooklyn 86
Grevenbroich 86
Norwalk 77
Falls Church 74
Toronto 71
Denver 70
Frankfurt am Main 69
Atlanta 67
Hangzhou 67
Da Nang 66
Chicago 63
Nuremberg 63
Changsha 62
Manchester 61
Stockholm 61
Johannesburg 60
Vienna 58
Seattle 57
Haiphong 56
Brussels 55
Jinan 55
Rio de Janeiro 55
Phoenix 54
Poplar 53
Amsterdam 52
Dong Ket 52
Mexico City 52
Brno 45
Belo Horizonte 44
Lanzhou 42
Baghdad 40
Mumbai 40
Seoul 40
Boston 39
Florence 32
Guangzhou 32
Ningbo 32
Tashkent 32
Biên Hòa 31
San Francisco 31
Brasília 30
Leawood 30
Taizhou 30
Charlotte 29
Naples 29
Shanghai 29
Totale 33.085
Nome #
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 1.088
Emergenza neurologica - tempesta distonica: diagnosi e terapia 483
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 344
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 313
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 278
REGIONE ABRUZZO. POTENZIAMENTO DELLA DIAGNOSI PRECOCE DEL DISTURBO NEUROCOGNITIVO MINORE TRAMITE IMPLEMENTAZIONE DI UN MINIMUM DATASET E DI TECNICHE DI INTELLIGENZA ARTIFICIALE 216
Pre-trattamento antiematico per Test/terapia all'apomorfina 197
Ambiguity resolution in relative clauses: An ERPs study. 192
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 184
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 183
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 182
Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis 180
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 178
null 177
"CADASIL coma" in an Italian homozygous CADASIL patient: comparison with clinical and MRI findings in age-matched heterozygous patients with the same G528C NOTCH3 mutation 177
The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis 177
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 176
GABA levels in the ventromedial prefrontal cortex during the viewing of appetitive and disgusting food images 176
GABA content within the ventro-medial prefrontal cortex is related to trait anxiety 171
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 171
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 164
Functional and neurochemical interactions within the amygdala-medial prefrontal cortex circuit and their relevance to emotional processing 163
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 163
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 163
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 162
Akinetic crisis in Dementia with Lewy Bodies 162
Ambiguity resolution and working memory span effects: An ERPs study 160
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 159
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 158
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 156
Specializzazione funzionale della corteccia visiva nell'uomo. Studio con risonanza magnetica funzionale e potenziali evocati visivi 155
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 155
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 154
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 153
Noun animacy and ERP components modulation 152
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 152
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 152
Fisiopatologia dei ritardi di conduzione nella sclerosi multipla 150
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 149
A combined EEG MEG fMRI study of the cortical activaties following pattern reversal visual stimuli 149
Progetto atrofia multisistemica: risultati preliminari. 149
Abnormal BAEP and internal auditory canal MRI in intracranial hypotension 148
Asymptomatic carotid acute dissection following focal status epilepticus. 148
ALZHEIMER DISEASE AND LEWY BODY DEMENTIA CAN BE DISTINGUISHED BY THE CYTOMETRIC IDENTIFICATION OF A NOVEL DIAGNOSTIC BIOMARKER 147
GABA content within medial prefrontal cortex predicts the variability of fronto-limbic effective connectivity 147
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 147
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 147
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 146
A Critical Review of Alien Limb-Related Phenomena and Implications for Functional Magnetic Resonance Imaging Studies 146
Atrophy of hippocampal subfields and amygdala nuclei in subjects with mild cognitive impairment progressing to Alzheimer's disease 145
Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder: A Pilot Study 145
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 145
BRAIN-STEM ACOUSTIC EVOKED-POTENTIALS (BAEPS) IN NEUROSURGICAL DISEASES 145
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 144
Bipallidal lesions induce delayed and progressive parkinsonism 143
Monitoraggio in vivo, con Risonanza Magnetica Morfologica (MRI) e Spettroscopica (H-MRS), dei cambiamenti metabolici e morfologici sulla via nigro-striatale indotti dal trattamento con PSI in un modello animale di Parkinson 142
Cerebral mapping in patients with multifocal diffractive intraocular lens 141
A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum 141
Tolcapone vs entacapone: efficacia ed effetti collaterali nel trattamento della sindrome di Parkinson 140
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 140
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 139
Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence 139
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 139
Autoscopic phenomena: case report and review of literature. 138
Attention network in AD and DLB patients: a resting fMRI study. 138
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 138
Data of safety in a single-center alemtuzumab treated population 138
Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report 137
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 137
Improving diagnostic accuracy of DLB: An MRI study 136
Amantadine for dyskinesia in patients affected by severe Parkinson's disease. 135
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 135
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 134
Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease 134
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 134
Instabilità posturale nel Parkinson non farmaco-responder 133
Holmes-Like Tremor in Ataxia With Oculomotor Apraxia Type 2 133
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 132
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 132
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 132
Neuromagnetic responses reveal the cortical timing of audiovisual synchrony 132
Acute akinesia or akinetic crisis in Parkinson's disease. 131
Acting before; a combined strategy to counteract the onset and progression of dementia 131
Stormy onset of benign childhood epilepsy with occipital paroxysmal discharges 130
Echo long time STIR sequence magnetic resonance imaging of optic nerves in optic neuritis 130
Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis 129
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 129
Hemispheric lateralization in top-down attention during spatial relation processing: a Granger causal model approach 129
A case of Sars-Cov-2-related mania with prominent psychosis> 129
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 128
Home-based palliative approach for people with severe multiple sclerosis and their carers: Study protocol for a randomized controlled trial 128
Heat shock protein 70: implication for Alzheimer's disease 127
Olanzapina: il nuovo trattamento della Sindrome di Gilles de La Tourette 126
Donepezil vs vitamina E nella malattia di Alzheimer (AD): confronto tra P300 Event Related Potential e Test Neuropsicologici. 126
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 126
L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain 125
3D localization of interictal epileptic activity by neuromagnetic method 125
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 125
A subtle mimicker in emergency department: Illustrated case reports of acute drug-induced dystonia 125
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 124
Totale 16.538
Categoria #
all - tutte 222.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 222.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021738 0 0 0 0 0 0 0 0 0 374 194 170
2021/20222.267 65 44 52 234 133 82 79 221 219 80 315 743
2022/20237.654 636 980 490 811 716 1.449 457 537 930 105 212 331
2023/20243.724 241 153 268 166 220 1.067 801 181 65 117 67 378
2024/20259.094 508 1.566 1.324 242 256 359 389 541 807 543 998 1.561
2025/202618.323 1.634 711 1.969 2.560 1.791 1.261 3.185 1.203 2.606 1.403 0 0
Totale 57.239